Oral News and Research

RSS

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved AJOVY injection for the preventive treatment of migraine in adults.

17 Sep 2018

FDA-approved 'safe' daily BPA exposure may contribute to insulin resistance

In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release.

17 Sep 2018

New project aims to increase patient willingness to take life-saving oral drugs

A new collaboration grant to scientists from Discovery BioMed, Inc. and the Monell Center will support development of next-generation screening technologies to enable identification of bitter taste blockers.

14 Sep 2018

New statement provides detailed overview of how to diagnose, treat resistant hypertension

Resistant hypertension affects 12 percent to15 percent of patients treated for high blood pressure according to a new scientific statement from the American Heart Association.

14 Sep 2018

Clinical trial begins to find better treatment for chronic cases of PKDL in Africa

A clinical trial to find a better treatment for severe or chronic cases of post kala-azar dermal leishmaniasis (PKDL) in Africa has begun in Dooka, Sudan.

12 Sep 2018

Inhaled form of high blood pressure drug has potential to treat anxiety, pain

An inhaled form of a high blood pressure medication has potential to treat certain types of anxiety as well as pain, according to a new study by the Centre for Addiction and Mental Health.

11 Sep 2018

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Platelet inhibition with aspirin is the cornerstone of medical therapy for coronary artery disease. In the era of percutaneous coronary intervention with drug-eluting stents, dual anti-platelet therapy with the addition of clopidogrel became the mainstay of therapy.

11 Sep 2018

Anticoagulant use in East Asian patients with nonvalvular atrial fibrillation

In the current issue of Cardiovascular Innovations and Applications (Volume3,Number 2, 2018, pp. 215-226(12); DOI: https://doi.org/10.15212/CVIA.2017.0033 Chang-Sheng Ma from the Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, Beijing, China considers the use of direct oral anticoagulants for prevention of stroke and systemic embolic events in East Asian patients with nonvalvular atrial fibrillation.

11 Sep 2018

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.

7 Sep 2018

Virtual 3D-printed surgical model improves bone regeneration

Dental implant technology has advanced greatly over the past few decades, allowing for more cost effective procedures. Often, when a patient loses teeth due to trauma or disease, bone loss ensues that makes it difficult or impossible to use dentures or dental implants.

7 Sep 2018

Telehealth videoconferencing promotes antibiotic stewardship efforts in rural facilities

A pilot project at two rural VA medical centers demonstrated that telehealth videoconferencing promoted antibiotic stewardship efforts by linking remote facilities to infectious diseases-trained professionals, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

6 Sep 2018

Mycovia initiates two Phase 3 clinical trials to evaluate VT-1161 in patients with RVVC

Mycovia Pharmaceuticals, making its official debut as a company developing therapies in women's health and dermatology, today announced the initiation of two Phase 3 clinical trials called VIOLET to evaluate the safety and efficacy of its lead candidate, VT-1161, in patients with recurrent vulvovaginal candidiasis

6 Sep 2018

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem, Inc., operating as Verastem Oncology, a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced dosing of the first patient in a multicenter Phase I/II clinical trial at the Dana-Farber/Harvard Cancer Center of duvelisib in combination with venetoclax in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

6 Sep 2018

Oral News and Research

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

FDA-approved 'safe' daily BPA exposure may contribute to insulin resistance

New project aims to increase patient willingness to take life-saving oral drugs

New statement provides detailed overview of how to diagnose, treat resistant hypertension

Clinical trial begins to find better treatment for chronic cases of PKDL in Africa

Inhaled form of high blood pressure drug has potential to treat anxiety, pain

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Anticoagulant use in East Asian patients with nonvalvular atrial fibrillation

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

Virtual 3D-printed surgical model improves bone regeneration

Telehealth videoconferencing promotes antibiotic stewardship efforts in rural facilities

Mycovia initiates two Phase 3 clinical trials to evaluate VT-1161 in patients with RVVC

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Good skin care practices can help teens to battle stubborn acne

Researchers find bacterial DNA in intestine of newborn calves

Bile acids reduce desire for cocaine, finds study

UniSA researchers unearth potential cure for obesity

Clinical trial: Promising drug slows brain shrinkage in progressive MS patients

Dectin-1 pathway could be important new target for treatment of candidiasis, study shows

Routine oral care to treat gum disease may improve cognitive function in cirrhosis patients

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News